Cargando…
Thrombotic microangiopathy (TMA) in adult patients with solid tumors: a challenging complication in the era of emerging anticancer therapies
Thrombotic microangiopathy (TMA) is a syndrome that encompasses a group of disorders defined by the presence of endothelial damage leading to abnormal activation of coagulation, microangiopathic hemolytic anemia and thrombocytopenia, occlusive (micro)vascular dysfunction, and organ damage. TMA may o...
Autores principales: | Font, Carme, de Herreros, Marta García, Tsoukalas, Nikolaos, Brito-Dellan, Norman, Espósito, Francis, Escalante, Carmen, Oo, Thein Hlaing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095052/ https://www.ncbi.nlm.nih.gov/pubmed/35545722 http://dx.doi.org/10.1007/s00520-022-06935-5 |
Ejemplares similares
-
Thrombosis, cancer, and COVID-19
por: Brito-Dellan, Norman, et al.
Publicado: (2022) -
Complexity and clinical significance of drug–drug interactions (DDIs) in oncology: challenging issues in the care of patients regarding cancer-associated thrombosis (CAT)
por: Tsoukalas, Nikolaos, et al.
Publicado: (2022) -
Carfilzomib-induced thrombotic microangiopathy (TMA): an under-recognised spectrum of disease from microangiopathic haemolysis to subclinical TMA
por: Ponraj, Royston, et al.
Publicado: (2023) -
A comprehensive model for assessing and classifying patients with thrombotic microangiopathy: the TMA-INSIGHT score
por: Addad, Vanessa Vilani, et al.
Publicado: (2023) -
P1344: METHODOLOGY OF AN INTERNATIONAL MULTI-CENTER RETROSPECTIVE REVIEW OF TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY (TA-TMA) BY THE TA-TMA WORKING GROUP
por: Ho, V., et al.
Publicado: (2022)